Ponsegromab treatment led to sustained weight gain and GDF-15 suppression over 64 weeks in cancer-associated cachexia patients. Patients initially on placebo gained weight after switching to ...
On Saturday April 5, Anavex announced data from their open-label extension trial, ATTENTION-AD, for early Alzheimer's Disease presented at the AD/PDTM 2025 Conference. ATTENTION-AD is a follow-on ...
In a randomized clinical trial, researchers found participants with moderate to severe irritable bowel syndrome (IBS) who were knowingly treated with a pharmacologically inactive pill -- referred to ...
Clinical trials are vital for the design and development of safe drugs, treatments, and medical interventions and bringing them to market. Often, the idea for a clinical trial starts in the laboratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results